Flen Health
Marie Van der Gucht is a Research Manager at Flen Health, specializing in the management of research projects aimed at identifying and developing new therapeutic applications in wound care since January 2022. Prior to this role, Marie served as an R&D Project Development Specialist and SB PhD Fellow at Fonds Wetenschappelijk Onderzoek - Vlaanderen, focusing on the exploration of novel bacteriophage-derived proteins and their potential biotechnological applications during the PhD studies at KU Leuven from January 2018 to December 2021. Marie's academic background includes a Master of Science and a Bachelor of Science in Bioscience Engineering from KU Leuven, along with additional educational experiences at the University of Chemistry and Technology in Prague and St. Gabriëlcollege Boechout.
This person is not in any teams
This person is not in any offices
Flen Health
Flen Health Live the Life you love! Flen Health believes biotech innovations can help to build a securer life for you and for every human being. Flen Health wants to improve the quality of life of people suffering from skin disorders in a responsible way, by providing added value for patients, healthcare professionals, health authorities and the environment. Flen Health was established in 2000, building on the results of wound-treatment research performed by its managing director, Philippe Sollie, a pharmacist. Based on patented technologies, Flen Health developed and commercializes a number of innovative wound and skin healing solutions. Flen Health holds an ISO 13485 certificate that covers all its operations. Thanks to the success on the Belgian market, Flen Health initiated its international expansion. This resulted in the establishment of further affiliates across Europe (in The Netherlands, Luxembourg, UK & Germany), managed by over 100 motivated employees. Flen Health products are distributed in 25 countries all over the world. Current product portfolio: Flaminal® Hydro, Flaminal® Forte, Flamigel®, Flamigel®RT, Flamirins® and extracalm®. Direct customers are mainly healthcare professionals: Flaminal® Hydro/Forte indicated for all kind of wound treatments and Flamigel® RT for skin damage caused by radiotherapy. Flen Health continues to expand its activities and invites motivated and dynamic people to join. Feel welcome to visit our website for more information: